Does Florida Medicaid cover Wegovy, Ozempic & Zepbound? (2026)
✓ Verified against Florida AHCA drug criteria
By Hemant Adhikari, founder of WillItCover · Digested from Florida AHCA Medicaid GLP-1 drug criteria · Last verified July 7, 2026
Short answer: only for diabetes, not weight loss. Florida Medicaid does not cover Wegovy or Zepbound for weight loss. It covers GLP-1 drugs used for type 2 diabetes — Ozempic, Mounjaro, Trulicity, Victoza and others — with prior authorization. Anti-obesity drugs are not a covered Florida Medicaid benefit, so patients seeking a GLP-1 purely for weight loss almost always end up paying cash.
Florida is among the strictest states on this: weight-loss GLP-1s aren't covered under its Statewide Medicaid Managed Care program. The coverage that exists is a diabetes benefit, gated by prior authorization. Here's what that means.
What's covered — GLP-1s for type 2 diabetes
GLP-1 drugs prescribed for type 2 diabetes can be covered with an approved prior authorization, including:
- Ozempic and Rybelsus (semaglutide)
- Mounjaro (tirzepatide)
- Trulicity (dulaglutide)
- Victoza (liraglutide)
Wegovy and Zepbound — the obesity-labeled versions of semaglutide and tirzepatide — are not covered for weight loss. The same molecule (for example, semaglutide) may be covered as the diabetes brand Ozempic but not as the weight-loss brand Wegovy.
The prior-authorization picture
Florida's Agency for Health Care Administration (AHCA) publishes clinical prior-authorization criteria for GLP-1 receptor agonists. In line with typical Medicaid diabetes rules, expect the PA to look for:
- a documented type 2 diabetes diagnosis;
- a trial of a first-line oral diabetes medication such as metformin (step therapy);
- use consistent with the drug's FDA-approved diabetes labeling; and
- no safety contraindications.
Florida Medicaid GLP-1 coverage is limited to type 2 diabetes with prior authorization; weight-loss use is not a covered benefit. AHCA's "Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Criteria" were most recently updated March 13, 2026 (published on AHCA's Prescribed Drugs — Drug Criteria page). Managed-care plans (for example Sunshine Health, Simply Healthcare, Humana) may apply their own preferred drug lists and steps. Confirm the current criteria with AHCA or your plan. Last verified July 7, 2026.
If you need a GLP-1 for weight loss
- Talk to your prescriber about the diabetes picture. If you have type 2 diabetes or meet the criteria above, a covered GLP-1 like Ozempic or Mounjaro may be an option — a genuine clinical path, not a loophole.
- Weight-loss surgery may be covered even though the drugs aren't. Bariatric surgery is a separate Medicaid benefit with its own medical-necessity criteria.
- If you also have Medicare (dual-eligible), the new Medicare GLP-1 Bridge — a federal demonstration running July 1, 2026–Dec 31, 2027 — offers Wegovy and a Zepbound formulation at a flat $50/month copay for those who qualify. See how the Bridge works →
- Cash and manufacturer programs. Novo Nordisk (NovoCare) and Eli Lilly (LillyDirect) run self-pay options that some patients use when insurance won't cover the drug for weight loss.
Will your GLP-1 be approved? Check in two minutes
Tell us your plan, drug and reason, and see whether you're likely covered — plus exactly what your prescriber should document.
Check my coverage
Frequently asked questions
Does Florida Medicaid cover Ozempic?
Yes — for type 2 diabetes, with prior authorization. Florida Medicaid covers GLP-1 drugs like Ozempic for diabetes when the AHCA clinical criteria are met, which typically include a documented diabetes diagnosis and a trial of a first-line oral medication such as metformin. Ozempic is not covered for weight loss.
Does Florida Medicaid cover Wegovy or Zepbound for weight loss?
No. Florida Medicaid does not cover anti-obesity GLP-1s like Wegovy or Zepbound for weight loss. GLP-1 coverage is limited to type 2 diabetes with prior authorization.
Does Florida Medicaid cover Mounjaro?
Yes, for type 2 diabetes with prior authorization, under AHCA's GLP-1 criteria. Mounjaro (tirzepatide) is the diabetes brand; Zepbound is the weight-loss brand of the same molecule and is not covered for weight loss.
Do I have to try metformin first?
Generally yes. Florida Medicaid's GLP-1 criteria, like most Medicaid diabetes rules, typically expect a trial of a first-line oral diabetes medication such as metformin before a GLP-1 is approved. Your prescriber can document why a step should be waived if it's not appropriate for you.
Where can I see Florida's exact GLP-1 rules?
Florida's Agency for Health Care Administration (AHCA) posts its "Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Criteria" on its Prescribed Drugs — Drug Criteria page; the criteria were last updated March 13, 2026. Your specific managed-care plan may also publish its own preferred drug list and steps.
How we know this: this page is based on Florida AHCA Medicaid GLP-1 receptor agonist drug criteria and the state's coverage of these drugs for type 2 diabetes only. Medicaid drug rules change frequently and managed-care plans vary — we re-verify this page against the source and date it. Last verified July 7, 2026. This is general information, not medical or coverage advice, and not a guarantee — your specific plan controls.
Related: Weight-loss coverage — the full guide · Does Medicare cover Wegovy? · California Medi-Cal · Texas Medicaid · GLP-1 coverage by insurer